Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa

Table 1 Chemotherapy medicine availability in South Africa per healthcare sector.

Healthcare Sector	Guideline chemotherapy selection	Medicines available
Public	Department of Health Master Procurement Catalogue (EML and STG)	5-FU (+LV), Capecitabine, Oxaliplatin, ^aIrinotecan
Private	Various medical aid scheme formularies for the South African Health Products Regulatory Authority (previously Medicines Control Council) approved medicines	5-FU (+LV), Capecitabine, Oxaliplatin, Irinotecan, Bevacizumab, Cetuximab, ^bPanitumumab, ^cAflibercept, ^bRegorafenib

^a Subsequent to this study has been approved for use in the public sector. Medicines underlined are available in both healthcare sectors.
^bSubsequent to this study Panitumumab and Regorafenib have been approved for use by SAHPRA - South African Health Products Regulatory Authority – but was previously available through a Section 21named patient use application.
^cNot yet registered for use in South Africa but is available through Section 21 named patient application.

ISSN: 1472-6963